Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Girard

Showing results (211-220 of 396) with videos related to

Pageof 40
Sort By:
Lung Cancer (Amsterdam, Netherlands)|May 21, 2022
Amivantamab compared with real-world therapies in patients with advanced non-small cell lung cancer harboring EGFR exon 20 insertion mutations who progressed after platinum-based chemotherapyAnna Minchom, Santiago Viteri, Lyudmila Bazhenova, et al.
Acta Oncologica (Stockholm, Sweden)|November 8, 2023
Amivantamab compared with real-world therapies in patients with advanced non-small cell lung cancer <i>EGFR</i> Exon 20 insertion mutations after platinum-based chemotherapyTae Min Kim, Nicolas Girard, Grace Kah Mun Low, et al.
Lung Cancer (Amsterdam, Netherlands)|November 14, 2021
Treatment strategies for unresectable locally advanced non-small cell lung cancer in the real-life ESME cohortNicolas Girard, Maurice Perol, Gaëtane Simon, et al.
Archives of Pathology & Laboratory Medicine|June 23, 2022
A Combination of MTAP and p16 Immunohistochemistry Can Substitute for CDKN2A Fluorescence In Situ Hybridization in Diagnosis and Prognosis of Pleural MesotheliomasLuka Brcic, Nolwenn Le Stang, Florian Gallob, et al.
Mediastinum (Hong Kong, China)|February 4, 2022
Case presentations and recommendations from the 2018 ITMIG Annual MeetingSamantha Sigurdson, Nikitha Moideen, Edith M Marom, et al.
Immunologic Research|August 27, 2016
Pulmonary hyalinizing granuloma: a multicenter study of 5 new cases and review of the 135 cases of the literatureRaphael Lhote, Julien Haroche, Loïc Duron, et al.
Lung Cancer (Amsterdam, Netherlands)|November 24, 2021
Comparative clinical outcomes for patients with advanced NSCLC harboring EGFR exon 20 insertion mutations and common EGFR mutationsLyudmila Bazhenova, Anna Minchom, Santiago Viteri, et al.
Scientific Reports|March 25, 2016
Hedgehog associated to microparticles inhibits adipocyte differentiation via a non-canonical pathwayAudrey Fleury, Lucile Hoch, M Carmen Martinez, et al.
Cancers|August 14, 2020
Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line PembrolizumabRomain-David Seban, Jean-Baptiste Assié, Etienne Giroux-Leprieur, et al.
Clinical Lung Cancer|July 26, 2025
Clinical Outcomes of Compound EGFR Mutations in Non-Small Cell Lung Cancer: A National, Retrospective, Multicenter StudyLina Atlagh, Anne-Claire Toublanc, Benoit Roch, et al.
Pageof 40

Showing results (211-220 of 396) with videos related to

Sort By:
Pageof 40
Lung Cancer (Amsterdam, Netherlands)|May 21, 2022
Amivantamab compared with real-world therapies in patients with advanced non-small cell lung cancer harboring EGFR exon 20 insertion mutations who progressed after platinum-based chemotherapyAnna Minchom, Santiago Viteri, Lyudmila Bazhenova, et al.
Acta Oncologica (Stockholm, Sweden)|November 8, 2023
Amivantamab compared with real-world therapies in patients with advanced non-small cell lung cancer <i>EGFR</i> Exon 20 insertion mutations after platinum-based chemotherapyTae Min Kim, Nicolas Girard, Grace Kah Mun Low, et al.
Lung Cancer (Amsterdam, Netherlands)|November 14, 2021
Treatment strategies for unresectable locally advanced non-small cell lung cancer in the real-life ESME cohortNicolas Girard, Maurice Perol, Gaëtane Simon, et al.
Archives of Pathology & Laboratory Medicine|June 23, 2022
A Combination of MTAP and p16 Immunohistochemistry Can Substitute for CDKN2A Fluorescence In Situ Hybridization in Diagnosis and Prognosis of Pleural MesotheliomasLuka Brcic, Nolwenn Le Stang, Florian Gallob, et al.
Mediastinum (Hong Kong, China)|February 4, 2022
Case presentations and recommendations from the 2018 ITMIG Annual MeetingSamantha Sigurdson, Nikitha Moideen, Edith M Marom, et al.
Immunologic Research|August 27, 2016
Pulmonary hyalinizing granuloma: a multicenter study of 5 new cases and review of the 135 cases of the literatureRaphael Lhote, Julien Haroche, Loïc Duron, et al.
Lung Cancer (Amsterdam, Netherlands)|November 24, 2021
Comparative clinical outcomes for patients with advanced NSCLC harboring EGFR exon 20 insertion mutations and common EGFR mutationsLyudmila Bazhenova, Anna Minchom, Santiago Viteri, et al.
Scientific Reports|March 25, 2016
Hedgehog associated to microparticles inhibits adipocyte differentiation via a non-canonical pathwayAudrey Fleury, Lucile Hoch, M Carmen Martinez, et al.
Cancers|August 14, 2020
Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line PembrolizumabRomain-David Seban, Jean-Baptiste Assié, Etienne Giroux-Leprieur, et al.
Clinical Lung Cancer|July 26, 2025
Clinical Outcomes of Compound EGFR Mutations in Non-Small Cell Lung Cancer: A National, Retrospective, Multicenter StudyLina Atlagh, Anne-Claire Toublanc, Benoit Roch, et al.
Pageof 40